Seroprevalence of antibodies to SARS-CoV-2 in 10 US sites
What The Study Did: This study estimates how common SARS-CoV-2 antibodies are in convenience samples from 10 geographic sites in the United States.
Authors: Fiona P. Havers, M.D., M.H.S., of the CDC COVID-19 Response Team at the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https:/
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
Media advisory: The full study and editorial are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https:/
JAMA Network Media Relations